A NEW type of antidepressant
may bring instant relief to people
suffering serious suicidal thoughts.
US researchers say the chemical
known as “CGP3466B” works in a
similar way to ketamine but with
much fewer negative side effects.
It will take several years to trial
CGP3466B as a human antidepressant,
but the compound,
developed late last century by
pharmaceutical giant Novartis has
been found to be non-addictive and
non-toxic.
New research on the chemical is
being led by neuroscientists from
Johns Hopkins Medicine.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jan 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jan 16
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.